BIO recently applauded the approval of the Senate Health Committee's Innovation Initiative.
+ Technology/Innovation
Jamie Barrand | Feb 15, 2016

BIO lauds passage of Health Committee's Innovation Initiative

The U.S. Senate Health Committee recently approved legislative facets of the Innovation Initiative, a program aimed at making medical advancements happen more quickly.

This move was lauded by representatives of the Biotechnology Innovation Organization (BIO), the world's largest biotechnology trade association. The international organization comprises members from 30 countries around the world -- members involved in research and development of biotechnology applications in the health care, agriculture, industrial and environmental sectors.

“BIO is extremely encouraged by the broad bipartisan votes yesterday by the Senate Health Committee to advance components of the Senate Innovation Initiative,” BIO President and CEO Jim Greenwood said. “We hope that these bills and others being considered by the committee as part of this initiative will continue to enjoy broad bipartisan support. We look forward to working with members of the committee on common-sense reforms that will improve the ecosystem of innovation which patients rely upon to deliver new treatments.”

Organizations in this story

More News